Century Therapeutics (IPSC) Competitors

Century Therapeutics (NASDAQ:IPSC) and Cryoport (NASDAQ:CYRX) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, valuation, earnings, community ranking, profitability, media sentiment, analyst recommendations, risk and institutional ownership.

Does the media refer more to IPSC or CYRX?

In the previous week, Century Therapeutics had 3 more articles in the media than Cryoport. MarketBeat recorded 5 mentions for Century Therapeutics and 2 mentions for Cryoport. Cryoport's average media sentiment score of 1.67 beat Century Therapeutics' score of 0.16 indicating that Cryoport is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Century Therapeutics	1 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Cryoport	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Do institutionals and insiders hold more shares of IPSC or CYRX?

50.2% of Century Therapeutics shares are held by institutional investors. Comparatively, 92.9% of Cryoport shares are held by institutional investors. 6.8% of Century Therapeutics shares are held by company insiders. Comparatively, 10.1% of Cryoport shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Is IPSC or CYRX more profitable?

Cryoport has a net margin of -70.08% compared to Century Therapeutics' net margin of -4,837.73%. Cryoport's return on equity of -13.35% beat Century Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Century Therapeutics	-4,837.73%	-61.66%	-31.78%
Cryoport	-70.08%	-13.35%	-6.43%

Do analysts prefer IPSC or CYRX?

Century Therapeutics currently has a consensus price target of $11.60, indicating a potential upside of 908.70%. Cryoport has a consensus price target of $12.50, indicating a potential upside of 55.86%. Given Century Therapeutics' stronger consensus rating and higher probable upside, research analysts clearly believe Century Therapeutics is more favorable than Cryoport.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Century Therapeutics	0 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	3.00
Cryoport	0 Sell rating(s)	3 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50

Does the MarketBeat Community believe in IPSC or CYRX?

Cryoport received 207 more outperform votes than Century Therapeutics when rated by MarketBeat users. However, 65.38% of users gave Century Therapeutics an outperform vote while only 64.96% of users gave Cryoport an outperform vote.

Company	Underperform	Outperform
Century Therapeutics	Outperform Votes 34 65.38%	Underperform Votes 18 34.62%
Cryoport	Outperform Votes 241 64.96%	Underperform Votes 130 35.04%

Which has more risk & volatility, IPSC or CYRX?

Century Therapeutics has a beta of 1.65, meaning that its stock price is 65% more volatile than the S&P 500. Comparatively, Cryoport has a beta of 1.62, meaning that its stock price is 62% more volatile than the S&P 500.

Which has stronger valuation and earnings, IPSC or CYRX?

Cryoport has higher revenue and earnings than Century Therapeutics. Cryoport is trading at a lower price-to-earnings ratio than Century Therapeutics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Century Therapeutics	$2.68M	36.43	-$136.67M	-$1.85	-0.62
Cryoport	$226.11M	1.75	-$99.59M	-$3.38	-2.37

Summary

Century Therapeutics and Cryoport tied by winning 9 of the 18 factors compared between the two stocks.